Herpesvirus Hominis Type 2 Infections in Rabbits: Effect of Prior Immunization with Attenuated Mycobacterium Bovis (BCG) Cells

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1972 Oct 1

PMID 4344024

Citations 13

Authors

C L Larson

R N USHIJIMA

R Karim

M B Baker

R E Baker

Affiliations

Soon will be listed here.

Abstract

Angora, New Zealand, and Dutch-belted rabbits were tested for their susceptibility to graded doses of Herpesvirus hominis type 2 administered by vaginal instillation, intracorneal injection, and scarification of the cornea. Central nervous system involvement and death occurred after infection by the various routes employed. Prior immunization of Dutch-belted and New Zealand rabbits with viable Mycobacterium bovis (BCG) cells injected intravenously provided protection against subsequent infections with type 2 virus.

Citing Articles

Bacille Calmette-Guérin: An ophthalmic perspective.

Jain M, Vadboncoeur J, Garg S, Biswas J Surv Ophthalmol. 2021; 67(2):307-320.

PMID: 34343536 PMC: 8325561. DOI: 10.1016/j.survophthal.2021.07.005.

Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.

Matthews T Infect Immun. 1981; 34(3):676-83.

PMID: 7333666 PMC: 350924. DOI: 10.1128/iai.34.3.676-683.1981.

Mechanisms of enhanced resistance of Mycobacterium bovis BCG-treated mice to ectromelia virus infection.

Sakuma T, Suenaga T, Yoshida I, Azuma M Infect Immun. 1983; 42(2):567-73.

PMID: 6315580 PMC: 264465. DOI: 10.1128/iai.42.2.567-573.1983.

Resistance of female mice to vaginal infection induced by Herpesvirus hominis type 2: effects of immunization with Mycobacterium bovis, intravenous injection of specific Herpesvirus hominis type 2 antiserum, and a combination of these procedures.

Baker M, Larson C, USHIJIMA R, Anderson F Infect Immun. 1974; 10(6):1230-4.

PMID: 4373394 PMC: 423092. DOI: 10.1128/iai.10.6.1230-1234.1974.

Effect of thymopentin on the mortality and immune response after an experimental herpes simplex infection in mice.

Cappel R, de Cuyper F, De Neef K, Hobel W, Bolla K Surv Immunol Res. 1985; 4 Suppl 1:48-57.

PMID: 3898292 DOI: 10.1007/BF02919056.

References

Mackaness G, Blanden R . Cellular immunity. Prog Allergy. 1967; 11:89-140. View

Brehmer W, Anacker R, Ribi E . Immunogenicity of cell walls from various mycobacteria against airborne tuberculosis in mice. J Bacteriol. 1968; 95(6):2000-4. PMC: 315125. DOI: 10.1128/jb.95.6.2000-2004.1968. View

Collins F . Recall of immunity in mice vaccinated with Salmonella enteritidis or Salmonella typhimurium. J Bacteriol. 1968; 95(6):2014-21. PMC: 315128. DOI: 10.1128/jb.95.6.2014-2021.1968. View

Rawls W, Tompkins W, Figueroa M, Melnick J . Herpesvirus type 2: association with carcinoma of the cervix. Science. 1968; 161(3847):1255-6. DOI: 10.1126/science.161.3847.1255. View

Park J, Baron S . Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA. Science. 1968; 162(3855):811-3. DOI: 10.1126/science.162.3855.811. View

COLEMAN V, Tsu E, JAWETZ E . "Treatment-resistance" to idoxuridine in herpetic keratitis. Proc Soc Exp Biol Med. 1968; 129(3):761-5. DOI: 10.3181/00379727-129-33419. View

NAIB Z, Nahmias A, Josey W, Kramer J . Genital herpetic infection. Association with cervical dysplasia and carcinoma. Cancer. 1969; 23(4):940-5. DOI: 10.1002/1097-0142(196904)23:4<940::aid-cncr2820230432>3.0.co;2-e. View

Mackaness G . The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969; 129(5):973-92. PMC: 2138649. DOI: 10.1084/jem.129.5.973. View

Rawls W, Tompkins W, Melnick J . The association of herpesvirus type 2 and carcinoma of the uterine cervix. Am J Epidemiol. 1969; 89(5):547-54. DOI: 10.1093/oxfordjournals.aje.a120967. View

10.

Blanden R . Increased antibacterial resistance and immunodepression during graft-versus-host reactions in mice. Transplantation. 1969; 7(6):484-97. DOI: 10.1097/00007890-196906000-00005. View

11.

Ruskin J, McIntosh J, Remington J . Studies on the mechanisms of resistance to phylogenetically diverse intracellular organisms. J Immunol. 1969; 103(2):252-9. View

12.

Zisman B, Hirsch M, Allison A . Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol. 1970; 104(5):1155-9. View

13.

Hirsch M, Zisman B, Allison A . Macrophages and age-dependent resistance to Herpes simplex virus in mice. J Immunol. 1970; 104(5):1160-5. View

14.

Royston I, Aurelian L . The association of genital herpesvirus with cervical atypia and carcinoma in situ. Am J Epidemiol. 1970; 91(6):531-8. DOI: 10.1093/oxfordjournals.aje.a121164. View

15.

Simon H, Sheagren J . Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity. J Exp Med. 1971; 133(6):1377-89. PMC: 2138929. DOI: 10.1084/jem.133.6.1377. View

16.

Mackaness G . Cellular immunity. Ann Inst Pasteur (Paris). 1971; 120(3):428-37. View

17.

McGregor D, Koster F, Mackaness G . The mediator of cellular immunity. I. The life-span and circulation dynamics of the immunologically committed lymphocyte. J Exp Med. 1971; 133(2):389-99. PMC: 2138898. DOI: 10.1084/jem.133.2.389. View

18.

Koster F, McGregor D, Mackaness G . The mediator of cellular immunity. II. Migration of immunologically committed lymphocytes into inflammatory exudates. J Exp Med. 1971; 133(2):400-9. PMC: 2138894. DOI: 10.1084/jem.133.2.400. View

19.

Moore C, Wallis C, Melnick J, Kuns M . Photodynamic treatment of herpes keratitis. Infect Immun. 1972; 5(2):169-71. PMC: 422342. DOI: 10.1128/iai.5.2.169-171.1972. View

20.

CLAFLIN J, Larson C . Infection-immunity in tularemia: specificity of cellular immunity. Infect Immun. 1972; 5(3):311-8. PMC: 422367. DOI: 10.1128/iai.5.3.311-318.1972. View